Added to YB: 2025-04-15
Pitch date: 2025-02-25
LNTH [bullish]
Lantheus Holdings, Inc.
-17.81%
current return
Author Info
No bio for this author
Company Info
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
Market Cap
$3.5B
Pitch Price
$81.00
Price Target
292.63 (+339%)
Dividend
N/A
EV/EBITDA
8.83
P/E
22.15
EV/Sales
2.46
Sector
Health Care Equipment and Supplies
Category
growth
Lantheus Holdings, Inc. - $LNTH
LNTH: Leading contrast imaging co. for prostate cancer & heart flow. Pylarify (70% rev) & Definity (80% mkt share) drive growth. Expanding into Alzheimer's via LMI acquisition. Strong financials: $1.4B rev, $460M op earnings, $370M FCF. Risks: patent expiry, regulatory approvals. Potential 20B mkt cap in 5-10 yrs.
Read full article (13 min)